Dr. Hinton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 center street
Ste 2f
Mobile, AL 36617Phone+1 251-660-5775Fax+1 251-435-6488
Summary
- Dr. John Hinton is a neurologist in Mobile, AL and is affiliated with multiple hospitals in the area, including Mobile Infirmary Medical Center, Rotary Rehabilitation Hospital, and Infirmary Long Term Acute Care Hospital. He received his medical degree from University of South Alabama College of Medicine and has been in practice 29 years. He specializes in sleep medicine and is experienced in general neurology, sleep medicine, neuro-rehabilitation, neurohospitalist, and hospice and palliative care.
Education & Training
- USA HealthResidency, Neurology, 1991 - 1994
- Atrium Health Navicent The Medical Center/Mercer University School of MedicineResidency, Surgery, 1988 - 1991
- University of South Alabama College of MedicineClass of 1988
Certifications & Licensure
- AL State Medical License 1991 - 2025
- GA State Medical License 1989 - 2025
- MS State Medical License 1993 - 2022
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Sleep Medicine
- National Board of Physicians and Surgeons Neurology
- National Board of Physicians and Surgeons Sleep Medicine
Publications & Presentations
PubMed
- 2 citationsLong-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.James F Howard Jr, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge
Therapeutic Advances in Neurological Disorders. 2024-01-01 - 42 citationsSafety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.James F Howard Jr, Saskia Bresch, Angela Genge, Channa Hewamadduma, John Hinton
The Lancet. Neurology. 2023-05-01 - 117 citationsClinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a ...James F. Howard, Richard Nowak, Gil I. Wolfe, Miriam L. Freimer, Tuan Vu
JAMA Neurology. 2020-05-01
Journal Articles
- Inhibition of Epidural Scar Formation Following Lumbar Laminectomy in the RatJohn Hinton et. al., spine Vol. 20, #5 pp. 564-570, 1/1/1995
Press Mentions
- University of Alabama Expands Health Care Reach With New Northport ClinicJanuary 20th, 2023
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: